MedKoo Cat#: 527650 | Name: IRAK-1/4 Inhibitor
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

IRAK-1/4 Inhibitor is a small-molecule compound that selectively targets interleukin-1 receptor-associated kinases 1 and 4 (IRAK1/4), key mediators in Toll-like receptor (TLR) and IL-1 receptor (IL-1R) signaling pathways. By inhibiting these kinases, the compound effectively blocks downstream activation of NF-κB and MAPK pathways, reducing the production of pro-inflammatory cytokines such as TNF-α and IL-6. It has demonstrated anti-inflammatory and immunomodulatory bioactivity, making it a promising therapeutic candidate for treating autoimmune diseases, chronic inflammation, and certain hematologic malignancies.

Chemical Structure

IRAK-1/4 Inhibitor
IRAK-1/4 Inhibitor
CAS#509093-47-4

Theoretical Analysis

MedKoo Cat#: 527650

Name: IRAK-1/4 Inhibitor

CAS#: 509093-47-4

Chemical Formula: C20H21N5O4

Exact Mass: 395.1594

Molecular Weight: 395.42

Elemental Analysis: C, 60.75; H, 5.35; N, 17.71; O, 16.18

Price and Availability

Size Price Availability Quantity
5mg USD 450.00 2 Weeks
10mg USD 650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
IRAK-1/4 Inhibitor
IUPAC/Chemical Name
N-[1-(2-Morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide
InChi Key
QTCFYQHZJIIHBS-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26)
SMILES Code
O=C(NC1=NC2=CC=CC=C2N1CCN3CCOCC3)C4=CC=CC([N+]([O-])=O)=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 395.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Talreja J, Talwar H, Ahmad N, Rastogi R, Samavati L. Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells. J Immunol. 2016 Aug 15;197(4):1368-78. doi: 10.4049/jimmunol.1600258. Epub 2016 Jul 11. PubMed PMID: 27402699; PubMed Central PMCID: PMC4975961. 2: Sekiguchi F, Matsumoto Y, Maeda Y, Tsubota-Matsunami M, Nishikawa H, Kawabata A. Biological activity of Helicobacter pylori components in mammalian cells: is it independent of proteinase-activated receptors? J Physiol Pharmacol. 2012 Dec;63(6):571-6. PubMed PMID: 23388472. 3: Bhattacharyya S, Borthakur A, Pant N, Dudeja PK, Tobacman JK. Bcl10 mediates LPS-induced activation of NF-kappaB and IL-8 in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2007 Aug;293(2):G429-37. Epub 2007 May 31. PubMed PMID: 17540779.